If you've opened Instagram lately and wondered why people have suddenly started saying PMOS instead of PCOS, you're not alone.

For years, Polycystic Ovary Syndrome (PCOS) has been one of the most commonly diagnosed hormonal conditions affecting women and people assigned female at birth. Now, after more than a decade of global discussion involving doctors, researchers, and people living with the condition, it has officially been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS). The change was announced in May 2026 through an international consensus published in The Lancet.

Which naturally raises the question:

Did the condition change?
No.

Will your diagnosis suddenly become invalid?
Also no.

So why change the name at all? Because, as it turns out, the old one was misleading from the very beginning.

PCOS Was Never Really About Ovarian Cysts

Despite what the name suggested, you never actually needed ovarian cysts to be diagnosed with PCOS. In fact, the "cysts" seen on ultrasound aren't cysts at all. They're small, immature follicles that haven't completed ovulation. Plenty of people with PCOS never have polycystic-looking ovaries, while many people without PCOS do.

That one word (polycystic) caused years of confusion.

Some people were told they couldn't possibly have PCOS because their ultrasound looked normal. Others believed the condition only affected fertility or periods because the name focused entirely on the ovaries.

What was actually happening was that the condition was affecting hormones, metabolism, skin, mental health, cardiovascular risk, and insulin resistance. And that name never reflected reality.

So, Why PMOS?

The new name stands for Polyendocrine Metabolic Ovarian Syndrome. It sounds intimidating, but each word serves a purpose.

Polyendocrine acknowledges that multiple hormones are involved, not just reproductive hormones.

Metabolic recognizes something doctors have known for years: many people with the condition experience insulin resistance and have a higher risk of developing conditions such as type 2 diabetes, fatty liver disease, and cardiovascular disease.

Ovarian stays because the ovaries are still involved, just not exclusively.

The new name shifts the focus from one organ to the whole body, which is a much more accurate description of what's actually happening. If you've ever felt like your PCOS affected far more than just your periods, you weren't imagining it. It can influence everything from energy levels and skin to mood, metabolism, and fertility. We explore those day-to-day effects in more detail in our guide on how PCOS impacts women's lives. 

Why This Actually Matters

At first glance, changing a name can seem like medical rebranding. But it's more than that.

Names influence how conditions are understood. Not just by patients, but by doctors too.

For years, many people with PCOS have described being bounced between specialists. A gynaecologist focused on irregular periods. A dermatologist treated acne. An endocrinologist looked at insulin resistance. A fertility specialist discussed ovulation. Sometimes nobody stepped back to connect the dots.

By putting "endocrine" and "metabolic" directly into the name, PMOS encourages a more holistic approach. It reminds healthcare providers that this isn't simply a reproductive condition. It's one that can affect multiple systems throughout the body.

That shift may seem subtle, but it has the potential to improve both diagnosis and long-term care.

Will Diagnosis Change?

Not immediately.

If you've already been diagnosed with PCOS, that diagnosis doesn't suddenly disappear because the name changed.

The internationally accepted diagnostic criteria remain the same during the transition period. Doctors still look at a combination of features such as irregular ovulation, signs of excess androgens (like acne or excess facial hair), and polycystic ovarian morphology on ultrasound, while ruling out other possible causes.

What may change is how doctors (and people in general) think about the condition once someone is diagnosed.

Instead of stopping at, "Your periods are irregular," there may be greater emphasis on screening for metabolic health, discussing long-term cardiovascular risk, monitoring blood sugar, and addressing mental health alongside reproductive symptoms. 

That broader approach also includes aspects of health that often get overlooked during appointments, like sexual wellbeing. Changes in libido, painful sex, body image, and vaginal dryness can all be part of the picture, yet many people are never warned about them. If that's something you've experienced, our blog PCOS and Sex: How PCOS Affects Libido & Ways to Manage dives into why it happens and what can help. 

In other words, the diagnosis stays the same. The conversation around it gets bigger.

What Are Indian Doctors Saying?

Many Indian endocrinologists and gynaecologists have welcomed the name change because it reflects what they've observed in clinics for years: PCOS was never just an ovarian disorder.

Speaking to Hindustan Times, endocrinologists noted that the old terminology often caused patients to focus only on fertility or ovarian "cysts," while overlooking the hormonal and metabolic aspects of the condition. The updated name better reflects the science and may encourage earlier diagnosis and more comprehensive care.

That's particularly relevant in India, where PCOS is already estimated to affect millions of women and is increasingly being diagnosed in adolescents and young adults. Delayed diagnosis, stigma around symptoms like excess facial hair or weight gain, and misconceptions that it is "only a fertility problem" continue to be common challenges.

As Dr. Rishma Pai puts it, "It's not just a name change, it's a complete approach and attitude change." For years, both patients and doctors focused on whether someone had ovarian cysts. The new name shifts the conversation toward what the condition actually is: a complex endocrine and metabolic disorder that can affect everything from menstrual cycles and fertility to insulin resistance, cardiovascular health and mental wellbeing. 

Dr. Pranav Ghody notes that "the older term was a misnomer" because the "cysts" seen on ultrasound are usually immature follicles rather than true ovarian cysts. That misunderstanding, he says, often confused patients and even delayed diagnosis. 

A name alone won't solve those problems, but it can start changing the conversation.

So… Should You Start Saying PMOS?

Eventually, probably.

For now, you'll likely see both terms used interchangeably.

Most doctors, hospitals, websites, and research papers will continue mentioning "PCOS" alongside "PMOS" while awareness catches up. International experts also expect a gradual transition rather than an overnight switch.

Think of it less as replacing your diagnosis and more as updating the language to better match what medicine already knows.

The Bottom Line

The name may have changed, but your body hasn't.

PMOS isn't a new disease. It's the same condition, described more accurately.

And that's important because words shape the way conditions are understood. For years, the term "PCOS" reduced a complex hormonal and metabolic disorder to ovaries and so-called cysts that weren't even true cysts. PMOS finally acknowledges what patients and doctors have known for a long time: this condition affects much more than your reproductive system.

The hope is that a better name leads to better conversations, earlier diagnosis, more comprehensive treatment, and fewer people being told, "Your scan is normal, so you can't possibly have PCOS."

Sometimes changing the name doesn't change the disease.

It changes whether people understand it.

About the Author

Madhu (she/her) has been an avid reader of all things spicy since her childhood. She writes sassy blog posts and listicles now so that others may benefit from her wholly inappropriate, wholly informative tastes, too.